
Vælg din etiket
vises direkte på hætteglassetLaboratorierapport
PDF- Testet
- GHK-Cu + KPV Blend 60mg
- Laboratorium
- Analiza Białek
- Dato
- October 2026
- Resultat
- 99% purity (GHK-Cu 95.54 mg + KPV 10.91 mg, 50 + 10 mg label)
- Endotoksiner
- 6.88 EU/vial
- Ordrenr.
- Adgangskode
Uafhængigt testet, kan verificeres med adgangskoden direkte hos laboratoriet.
GHK-Cu + KPV Blend
Healing
- Laboratorietestet · 99% renhed
- Sendes fra Tyskland
Bestilling
- DHL med sporing
- Diskret emballage
Kort fortalt
GHK-Cu + KPV Blend i tal
Nøgletallene fra vores leksikon.
Hele leksikonopslaget- Type
- Blend of two tripeptidesGHK-Cu + KPV
- Use
- Subcutaneous injection after reconstitution
- Sizes
- 60 mg1 size in the shop
What studies show
All 7 sources in the lexicon- BioMed Research International
- Journal of Biomaterials Science, Polymer Edition
- Macromolecular Bioscience
Anmeldelser
Hvad kunderne siger
Kun rigtige bestillinger, der indeholdt GHK-Cu + KPV Blend.
Alle anmeldelserViden
Alt om GHK-Cu + KPV Blend
Detaljerede oplysninger kommer snart.
Dosering
Indlæser doseringsinformation …
Godt at have
Det har du brug for til den
Bakteriostatisk vand lægges automatisk i din kurv. Sprøjter og servietter med ét klik.
Insulinsprøjter
10 stk. · 5.50 €
Spritservietter
50 stk. · 10 €
Hvor meget vand?
Enheder på sprøjten til din hætteglasstørrelse.
Åbn beregneren →Are there studies on the GHK-Cu + KPV Blend?
No. As of 26 October 2026 there is no study on the blend, neither on ClinicalTrials.gov nor in PubMed. The only paper naming both peptides is a review of tripeptides in wound healing without its own data on the blend. Only the single components have been studied.
Why these two peptides?
The idea is that the pathways complement each other: GHK-Cu on the side of building and collagen, KPV on the side of calming inflammation. This has not been tested. No study has examined whether the combination does more than either substance alone.
What is known about GHK-Cu in humans?
The best study is a randomised gel trial in diabetic foot ulcers: a median 98.5 percent of the wound area closed, versus 60.8 percent with vehicle gel. Other data come mainly from cosmetics. A recent review calls the clinical evidence sparse, there are no studies on injection.
What is known about KPV?
KPV enters gut and immune cells via the transporter PepT1 and inhibits the inflammation pathway NF-κB there even at nanomolar concentrations. In two colitis models in mice KPV in the drinking water reduced inflammation. In nanoparticles a 12,000-fold lower concentration was enough. In skin cells KPV triggered a calcium signal. There are no human studies.
Which side effects are known?
There are no data for the blend. In the GHK-Cu gel trial 7 percent of ulcers became infected, versus 34 percent with vehicle gel. Human safety data are missing for KPV and for GHK-Cu as an injection. A review of peptides in sport warns that robust safety data are missing for many of these substances.
Is the blend approved?
No. Neither the blend nor GHK-Cu or KPV is approved as a medicine (as of October 2026). ChEMBL lists GHK without a clinical phase and no trial of KPV is registered.
Relateret
Relaterede produkter
BPC-157
Peptider · Heling & restitution Heling & restitution
4 størrelser
Laboratorietestet
= fra 5.2 €/hætteglas
TB-500 (Thymosin B4)
Peptider · Heling & restitution Heling & restitution
3 størrelser
Laboratorietestet
= fra 18.8 €/hætteglas
TB-500 FRAG
Peptider · Heling & restitution Heling & restitution
1 størrelse
= 24.8 €/hætteglas
BPC + TB Blend
Peptider · Heling & restitution Heling & restitution
3 størrelser
Laboratorietestet
= fra 24.8 €/hætteglas
GHK-Cu + KPV Blend